Novavax COVID vaccine 90% effective in phase 3 trial Leave a Comment / By nigel / June 14, 2021 Mary Van Beusekom | News Writer | CIDRAP News Jun 14, 2021 The vaccine showed 100% protection against severe illness and 93% against variants of concern.
